Independent, evidence-informed, practical resources for physicians, pharmacists, & nurse practitioners. Based in the University of British Columbia's Faculty of Medicine, Department of Anesthesiology, Pharmacology & Therapeutics. #BetterPrescribing #MedEdhttps://bsky.app/profile/drug-evidence.bsky.socialhttps://bsky.app/profile/drug-evidence.bsky.social/post/3mzo3qtana224🧵HAVE YOU REGISTERED FOR OUR ANNUAL COURSE? 1/ We've invited a stellar cast of experts to present at our course this year, including Dr. Tom Jefferson, Dr. Carl Heneghan, Dr. Jen Gunter, Dr. Evan Wood and many others! 👉Register now: ti.ubc.ca/course-2027 #DrugEvidence27 #CME06 Nov 2026 19:14 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mzo3qtana224https://bsky.app/profile/drug-evidence.bsky.social/post/3mzlenze25c2uMaryanne Demasi: What do #statins really offer the over 70s? https://blog.maryannedemasi.com/p/what-do-statins-really-offer-the https://blog.maryannedemasi.com/p/what-do-statins-really-offer-the?utm_campaign=email-post&r=21ypdj&utm_source=substack&utm_medium=email05 Nov 2026 17:16 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mzlenze25c2uhttps://bsky.app/profile/drug-evidence.bsky.social/post/3mzldxgqous2p🧵REGISTRATION NOW OPEN! 1/ Our #BestEvidence for Clinicians Annual Course tackles common + new drug therapy issues from an evidence-based perspective & is designed for physicians, nurse practitioners, pharmacists, students, & residents 👉Register now: ti.ubc.ca/course-2027 #DrugEvidence27 #CME05 Nov 2026 17:03 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mzldxgqous2phttps://bsky.app/profile/drug-evidence.bsky.social/post/3mzit6f7u422r🚨Our latest UBC TI #BestEvidence webinar recording! "Buprenorphine for opioid use disorder" 🎤 Speaker: Dr. Paxton Bach 💻 Recording: https://www.ti.ubc.ca/2026/10/28/buprenorphine-for-oud/ 👉 See also: TI Therapeutics Letter 163 ti.ubc.ca/letter163 #Buprenorphine #opioids #addictions04 Nov 2026 16:58 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mzit6f7u422rhttps://bsky.app/profile/drug-evidence.bsky.social/post/3mzhfhija6s2x🆕 Our latest UBC TI #BestEvidence webinar recording! 🆕 "Buprenorphine for opioid use disorder" 🎤 Speaker: Dr. Paxton Bach 💻 Recording: https://www.ti.ubc.ca/2026/10/28/buprenorphine-for-oud/ 👉 See also: TI Therapeutics Letter 163 ti.ubc.ca/letter163 #Buprenorphine #opioids #addictions04 Nov 2026 03:20 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mzhfhija6s2xhttps://bsky.app/profile/drug-evidence.bsky.social/post/3mze3sy4kck2cICYMI: UBC TI #Deprescribing webinar #9 "Optimizing Medications for Patients with Major Polypharmacy and Multiple Morbidities: Evidence and How to Apply It" Speaker: Dr. Anne Holbrook 👉 recording: http://ti.ubc.ca/deprescribing-webinar-9/ #MedEd #polypharmacy #BetterPrescribing02 Nov 2026 19:49 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mze3sy4kck2chttps://bsky.app/profile/drug-evidence.bsky.social/post/3mz4h56ruzk2u🆕 Safety of Sodium–Glucose Cotransporter 2 Inhibitors in Older Adults With Type 2 #Diabetes: A Cohort Study 🆕 https://diabetesjournals.org/care/article/doi/10.2337/dc26-1316/172876/Safety-of-Sodium-Glucose-Cotransporter-2 "SGLT2i initiation was not associated with increased risk of harm compared with DPP-4i initiation, although estimates were imprecise for some outcomes" https://diabetesjournals.org/care/article-abstract/doi/10.2337/dc26-1316/172876/Safety-of-Sodium-Glucose-Cotransporter-2?redirectedFrom=fulltext30 Oct 2026 18:50 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mz4h56ruzk2uhttps://bsky.app/profile/drug-evidence.bsky.social/post/3mz45stim7s2rICYMI: HOW OFTEN... should #A1c tests be used to monitor patients with #T2DM? 🤔 Find out in our #BestEvidence webinar recording: 👉 ti.ubc.ca/a1c-testing-webinar See also: 👉TI Therapeutics Letter 161 + patient handout: ti.ubc.ca/letter161 #MedEd #diabetes #labtesting30 Oct 2026 16:03 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mz45stim7s2rhttps://bsky.app/profile/drug-evidence.bsky.social/post/3myzsomgckc2p#BetterPrescribing -> Better Health ❤️💪 Physician? Nurse Practitioner? Pharmacist? Researcher?👩🏾‍⚕️👨‍⚕️ ✅ Never miss another UBC Therapeutics Initiative webinar, workshop, publication ✅ SUBSCRIBE to our Therapeutics Letters + events: https://e1.envoke.com/ext/pages/afd43c324e669856f9f5e3d963aba456 #independent #MedEd29 Oct 2026 17:39 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3myzsomgckc2phttps://bsky.app/profile/drug-evidence.bsky.social/post/3myxaa5uvls2g⌛️ TODAY (Oct 28) @ Noon Pacific ⌛️ TI #BestEvidence Webinar: Buprenorphine for opioid use disorder 🎤 Speaker: Dr. Paxton Bach ✍️ Register now: https://www.ti.ubc.ca/2026/10/20/buprenorphine-for-oud/ 👉 See also: TI Therapeutics Letter 163 ti.ubc.ca/letter163 #Buprenorphine #opioids #addictions28 Oct 2026 17:03 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3myxaa5uvls2ghttps://bsky.app/profile/drug-evidence.bsky.social/post/3myvbrtmnt22u🆕 Diagnosis and management of #prediabetes and early type 2 diabetes: a qualitative study of patient experiences https://bmjopen.bmj.com/content/16/10/e122021 This study explores experiences & perspectives on diagnosis/management among people living with prediabetes or early T2DM #diabetes #T2DM27 Oct 2026 22:26 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3myvbrtmnt22uhttps://bsky.app/profile/drug-evidence.bsky.social/post/3myuqp6ai5c2d⌛️ TOMORROW (Oct 28) @ Noon Pacific ⌛️ TI #BestEvidence Webinar: Buprenorphine for opioid use disorder 🎤 Speaker: Dr. Paxton Bach ✍️ Register now: https://www.ti.ubc.ca/2026/10/20/buprenorphine-for-oud/ 👉 See also: TI Therapeutics Letter 163 ti.ubc.ca/letter163 #Buprenorphine #opioids #addictions27 Oct 2026 17:20 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3myuqp6ai5c2dhttps://bsky.app/profile/drug-evidence.bsky.social/post/3mys5aoeqjk2nICYMI: UBC TI #Deprescribing webinar #9 "Optimizing Medications for Patients with Major Polypharmacy and Multiple Morbidities: Evidence and How to Apply It" Speaker: Dr. Anne Holbrook 👉 recording: http://ti.ubc.ca/deprescribing-webinar-9/ #MedEd #polypharmacy #BetterPrescribing26 Oct 2026 16:27 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mys5aoeqjk2nhttps://bsky.app/profile/drug-evidence.bsky.social/post/3mypvk653ms27🚨 TI #BestEvidence Webinar: Buprenorphine for opioid use disorder 🎤 Speaker: Dr. Paxton Bach ✍️ Register now: https://www.ti.ubc.ca/2026/10/20/buprenorphine-for-oud/ 👉 See also: TI Therapeutics Letter 163 ti.ubc.ca/letter163 #Buprenorphine #opioids #addictions25 Oct 2026 19:03 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mypvk653ms27https://bsky.app/profile/drug-evidence.bsky.social/post/3mykodgx2pc2aICYMI: UBC TI #Deprescribing webinar #9 "Optimizing Medications for Patients with Major Polypharmacy and Multiple Morbidities: Evidence and How to Apply It" Speaker: Dr. Anne Holbrook 👉 recording: http://ti.ubc.ca/deprescribing-webinar-9/ #MedEd #polypharmacy #BetterPrescribing23 Oct 2026 17:11 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mykodgx2pc2ahttps://bsky.app/profile/drug-evidence.bsky.social/post/3myiae7t5lc2c🚨 ICYMI: UBC TI #BestEvidence webinar recording Evidence-based approaches to #menopause: Overcoming #misinformation https://ti.ubc.ca/2026/05/05/evidence-based-approaches-to-menopause/ #MedEd #WomensHealth22 Oct 2026 17:56 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3myiae7t5lc2chttps://bsky.app/profile/drug-evidence.bsky.social/post/3myfu25eto22t🚨 TI #BestEvidence Webinar: Buprenorphine for opioid use disorder 🎤 Speaker: Dr. Paxton Bach ✍️ Register now: https://www.ti.ubc.ca/2026/10/20/buprenorphine-for-oud/ 👉 See also: TI Therapeutics Letter 163 ti.ubc.ca/letter163 #Buprenorphine #opioids #addictions21 Oct 2026 19:10 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3myfu25eto22thttps://bsky.app/profile/drug-evidence.bsky.social/post/3mydtifcq6s27🆕 TI #BestEvidence Webinar: Buprenorphine for opioid use disorder 🆕 🎤 Speaker: Dr. Paxton Bach ✍️ Register now: https://www.ti.ubc.ca/2026/10/20/buprenorphine-for-oud/ 👉 See also: TI Therapeutics Letter 163 ti.ubc.ca/letter163 #Buprenorphine #opioids #addictions20 Oct 2026 23:55 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mydtifcq6s27https://bsky.app/profile/drug-evidence.bsky.social/post/3mydsrvhrzk2c🆕 UBC TI Therapeutics Letter 163 🆕 Buprenorphine maintenance treatment for opioid use disorder 👉 ti.ubc.ca/letter163 Opioid agonist treatment such as buprenorphine-naloxone is the gold standard therapy that reduces mortality and improves quality of life 🥇 #Buprenorphine #opioids #addictions20 Oct 2026 23:42 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mydsrvhrzk2chttps://bsky.app/profile/drug-evidence.bsky.social/post/3mydmpeot7s22Rising #Escitalopram Use in British Columbia: Is it Rational and Evidence-Informed? https://www.ti.ubc.ca/2026/10/17/escitalopram-use-bc/ #prescribing20 Oct 2026 21:53 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mydmpeot7s22https://bsky.app/profile/drug-evidence.bsky.social/post/3mydmotgjfc2vEvaluation of the efficacy, safety and utilization of racemic mixtures versus single enantiomers in British Columbia primary care: a comprehensive review https://www.ti.ubc.ca/2026/10/17/evaluation-of-the-efficacy-safety-and-utilization-of-racemic-mixtures-versus-single-enantiomers-in-british-columbia-primary-care-a-comprehensive-review/20 Oct 2026 21:53 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mydmotgjfc2vhttps://bsky.app/profile/drug-evidence.bsky.social/post/3mydllekl222nICYMI: UBC TI #Deprescribing webinar #9 "Optimizing Medications for Patients with Major Polypharmacy and Multiple Morbidities: Evidence and How to Apply It" Speaker: Dr. Anne Holbrook 👉 recording: http://ti.ubc.ca/deprescribing-webinar-9/ #MedEd #polypharmacy #BetterPrescribing20 Oct 2026 21:33 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mydllekl222nhttps://bsky.app/profile/drug-evidence.bsky.social/post/3mydcznvbyk2nDrug company promotion negatively affects how doctors prescribe: Insights from a new @cochrane.org review https://theconversation.com/drug-company-promotion-negatively-affects-how-doctors-prescribe-insights-from-a-new-cochrane-review-292682 #prescribing #drugindustry #pharma #drugcosts20 Oct 2026 19:00 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mydcznvbyk2nhttps://bsky.app/profile/drug-evidence.bsky.social/post/3mydcne42qc2n🆕 Cochrane #SystematicReview: Pharmaceutical industry information and promotional strategies aimed at prescribers https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013423.pub3/full Gifts/payments from pharma companies to doctors increase INAPPROPRIATE #prescribing & the number of prescriptions that doctors write 💰🎁 #pharma20 Oct 2026 18:53 +0000at://did:plc:mx74732tkx74gqa7k4pivync/app.bsky.feed.post/3mydcne42qc2n